UK just approved the orforglipron pill - anyone here planning to ask for it?

MHRA gave the green light to orforglipron this morning, so private telehealth clinics will probably have it stocked soon, exciting news.
Hoping the added competition puts some pressure on pricing for the wegovy pill too.

The official line reads that, like every GLP-1 receptor agonist, safety and effectiveness will stay under close review going forward. UK's now first in Europe to approve it for both weight management and type 2 diabetes.

Still not officially approved yet, though it's in its final review stage and getting close. Runs significantly cheaper too. The older medication targets just one receptor pathway, while this newer one works across three separate receptor types. Delivers the same effects as the older option but also boosts metabolic rate on top of that.

Orforglipron, Lilly's pill with the awful name, got FDA approval back on the first of April (no kidding!). It's sold as Foundayo, which beats what I expected. Curious how the market takes it and where the price lands. I recall the numbers floated being around the Zepbound cash price for the uninsured, so not great...

Novo let its patent lapse in Canada, so generic GLP-1s are in production now. Expect other regions by 2030, at which point GLP-1s could turn as routine as aspirin. Obviously it doesn't hit multiple receptors like the newer ones, but I figure high enough doses give a similar effect at a fraction of the price.

Reading your title, I figured your pills were leaking lol. Wegovy and orforglipron already come as pills, and more are on the way. My favorites are the glp-1 plus amylin agonist combos, but those are way back in the pipeline. With the two giants dominating this market I'm surprised other companies pour in money. Apparently Pfizer wants to lead in obesity meds, and I think they have no drug on the market yet. The thinking seems to be that obesity medicine may become highly individualized someday.